Toshiba showcases Titan
Vantage Titan, a wide-bore 1.5T scanner, highlights MR offerings from Toshiba America Medical Systems at the RSNA meeting this week. The work-in-progress features a bore 18% wider than any 1.5T scanner currently on the market, according to the company. A specially designed gradient system offers an amplitude of 30 and a slew rate of 130 to expand the field-of-view.
Vantage Titan, a wide-bore 1.5T scanner, highlights MR offerings from Toshiba America Medical Systems at the RSNA meeting this week. The work-in-progress features a bore 18% wider than any 1.5T scanner currently on the market, according to the company. A specially designed gradient system offers an amplitude of 30 and a slew rate of 130 to expand the field-of-view.
Engineers built the system around the same magnet that is currently available on Toshiba's Atlas MRs. This will allow Atlas owners to field-upgrade to the Titan when it is commercially offered, which could happen early next year. Titan includes Toshiba's proprietary sound-muffling technology, Pianissimo.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
